Bandage for transdermally administering scopolamine to prevent nausea
AssigneeAlza Corporation
InventorsJohn Urquhart, Santosh Kumar Chandrasekaran, Jane Elizabeth Shaw
Life of this patent
Estimating the term…
Loading patent…
AssigneeAlza Corporation
InventorsJohn Urquhart, Santosh Kumar Chandrasekaran, Jane Elizabeth Shaw
Estimating the term…
Method and therapeutic system in the form of a bandage that administer scopolamine base transdermally in an initial pulse of 10 to 200 .mu.g/cm.sup.2 of skin that quickly brings the concentration of scopolamine in the plasma to a level at which emesis and nausea are inhibited without intolerable side effects, followed by a substantially constant dosage in the range of 0.3 to 15 .mu.g/hr that holds said level. The bandage is a four-layer laminate of, from the top: a protective backing; a gelled, mineral oil-polyisobutene-scopolamine reservoir lamina that is the source of the constant dosage; a microporous membrane that controls the constant dosage rate; and a gelled, mineral oil-polyisobutene-scopolamine adhesive layer that is the source of the pulse dose and the means by which the bandage is attached to the skin.
A therapeutic system in the form of a bandage for administering scopolamine base through unbroken skin to inhibit emesis and nausea for a prolonged time period comprising a sandwich-type laminate of:
Dependencies are inferred from the claim text.